Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

How to Use the Newly Authorized Oral Antiviral Agents for COVID-19

Hear expert insights on a stepwise approach to evaluate treatment candidacy for oral antiviral agents for COVID-19 and practical considerations for their use.
Kristen Marks, MD
Released: February 3, 2022

Information on this Educational Activity

Faculty

Kristen Marks, MD

Assistant Professor of Medicine
Division of Infectious Diseases
Weill Cornell Medicine
New York, New York

Kristen Marks, MD, has disclosed that she has received funds for research support paid to Weill Cornell Medicine from Gilead Sciences.

Program Medium

This program has been made available online.

Related Content

Expert faculty provide a comprehensive overview of current landscape of outpatient COVID-19 management strategies, from Clinical Care Options (CCO), Practicing Clinicians Exchange (PCE), and ProCE

Renslow Sherer, MD person default Trinh P. Vu, PharmD, BCIDP Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: November 22, 2022 Expired: November 21, 2023

Expert faculty discuss ways to improve the empiric treatment of HABP/VABP in the ICU in this commentary from Clinical Care Options (CCO)

person default Marion Elligsen, BScPhm, MSc, RPh, ACPR Keith S. Kaye, MD, MPH Andrew Shorr, MD, MPH, MBA Released: November 18, 2022

Dr Alicia Lichvar: importance of COVID-19 prevention in patients with immunocompromise, from Clinical Care Options (CCO)

person default Alicia Lichvar, PharmD, MS, BCPS, BCTXP Released: November 17, 2022

Dr Joseph Torrisi answers key questions regarding treatment considerations for nonhospitalized patients with acute COVID-19, from Clinical Care Options (CCO)

Joseph Torrisi, PharmD, BCIDP Released: November 17, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings